Dr. Singh is actively licensed & board certified in internal medicine. He is currently the CEO of gWell, Inc, a genomics and wellness focused digital health company, and serves as a senior advisor and board member for mission aligned companies and non-profits. In addition, he is an Adjunct Instructor of Medicine at Harvard Medical School. He was formerly Corporate Vice-President and Chief Medical Officer of Specialty Pharmacy at CVS Health.
Helix Laboratory earned FDA authorization for a whole exome sequencing platform, providing new hope to doctors and their patients.
Blockchain technology is being used to control results of genetic and genomic testing but as it evolves, privacy cannot be compromised.
CAR-T therapy is a revolutionary new cancer treatment. But should academic medical centers be able to manufacture their own?
A growing body of research has mapped Alzheimer's disease on a genetic level––including the recent discovery of two genes associated with an increased risk.
Specialty medications can be extremely expensive but there are financial assistance programs to help people with the costs of treating the condition.
With the rapid growth of the specialty pharmacy industry, technology is playing an important role in software, adherence, and data analysis.
Multiple sclerosis (MS) is an autoimmune disorder that affects the brain and there are various medications and treatment options that can help.
What are some health policy changes and payment reforms in the Biden administration? Will Americans hoping for quality healthcare finally get their wish?
Mobile features like one-way refill reminders, order status messages, and two-way clinical messaging help manage prescriptions and improve medication adherence
New technologies like mobile apps and online video libraries allow patients another way to make an informed decision but are only helpful with the doctor's involvement.
